Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Augmentation of Locomotor Adaptation Post-Stroke

26. juni 2018 oppdatert av: Medical University of South Carolina
This project will evaluate two different methods of normalizing the center of mass acceleration (COMa) in individuals post-stroke, specifically focusing on rates and pattern of recovery to analyze walking-specific adaptations as precursors to motor learning. In addition, the proposed project seeks to establish the optimal configuration of electrodes to activate neural circuits involved in post-stroke locomotion. Once the better method of training COMa and optimal parameters of electrode placement for tDCS are identified, the investigators will evaluate the effects of tDCS on locomotor adaptations during single sessions and over a five-day training period.

Studieoversikt

Status

Fullført

Forhold

Intervensjon / Behandling

Detaljert beskrivelse

The project seeks to establish the optimal configuration of electrodes to change the excitability of neural circuits involved in post-stroke locomotion, identify effective strategies for training a specific locomotor adaptation, and improve adaptations via adjunctive non-invasive brain stimulation. Tools to improve neural excitability may increase potential for locomotor skill learning, thereby improving rehabilitation outcomes. Non-invasive brain stimulation with transcranial direct current stimulation (tDCS) has recently emerged as a simple to administer, low-cost, and low-risk option for stimulating brain tissue. Cortical excitability is increased after application and preliminary results imply a relationship to increases in motor activity in those post-stroke. However, inhibition of the contralesional hemisphere is also shown to improve paretic motor output through inhibition of excessive maladaptive strategies, and combining the two electrode configurations may provide additional benefit for locomotor tasks requiring interlimb coordination. Furthermore, the effects of tDCS on walking function in conjunction with physical intervention strategies aimed at improving locomotor ability post-stroke are yet unstudied.

Studietype

Intervensjonell

Registrering (Faktiske)

29

Fase

  • Fase 1

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • South Carolina
      • Charleston, South Carolina, Forente stater, 29425
        • MUSC Center for Rehabilitation Research in Neurologic Conditions

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år til 85 år (Voksen, Eldre voksen)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria: Chronic Stroke

  1. age 18-70
  2. at least six month post-stroke
  3. residual paresis in the lower extremity (Fugl-Meyer LE motor score <34)
  4. ability to sit unsupported for ≥ 30 sec
  5. ability to walk at least 10 ft.
  6. self-selected 10 meter gait speed < 0.8 m/s
  7. provision of informed consent.

Exclusion Criteria: Acute Stroke

  1. Unable to ambulate at least 150 feet prior to stroke, or experienced intermittent claudication while walking < 200 meters
  2. history of congestive heart failure, unstable cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, angina or dyspnea at rest or during activities of daily living
  3. History of COPD or oxygen dependence
  4. Preexisting neurological disorders, dementia or previous stroke
  5. History of major head trauma
  6. Legal blindness or severe visual impairment
  7. history of significant psychiatric illness
  8. Life expectancy <1 yr
  9. Severe arthritis or orthopedic problems that limit passive ROM
  10. post-stroke depression (PHQ-9 ≥10)
  11. History of DVT or pulmonary embolism within 6 months
  12. Uncontrolled diabetes with recent weight loss, diabetic coma, or frequent insulin reactions
  13. Severe hypertension with systolic >200 mmHg and diastolic >110 mmHg at rest
  14. presence of cerebellar stroke.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Dobbelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Uphill COMa training
Walking on an inclined treadmill, thus manipulating the permissive environment to elicit COMa adaptation, while receiving either tDCS or sham tDCS.
Constant non-invasive, low intensity, direct electrical current utilized to stimulate specific areas of the brain. Evaluating immediate effects of anodal/cathodal stimulation during 20 minutes of treadmill walking.
Per published protocols, tDCS will be administered for 30 secs allowing for sensory adaptation to occur and then turned off, so that the remaining sham "stimulation" will include zero current. Evaluating immediate effects during 20 minutes walking on a treadmill.
Eksperimentell: Downhill COMa training
Walking on a declined treadmill, thus manipulating the permissive environment to elicit COMa adaptation, while receiving either tDCS or sham tDCS.
Constant non-invasive, low intensity, direct electrical current utilized to stimulate specific areas of the brain. Evaluating immediate effects of anodal/cathodal stimulation during 20 minutes of treadmill walking.
Per published protocols, tDCS will be administered for 30 secs allowing for sensory adaptation to occur and then turned off, so that the remaining sham "stimulation" will include zero current. Evaluating immediate effects during 20 minutes walking on a treadmill.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Center of Mass Acceleration Peak
Tidsramme: Pre (same as initial session) and post (immediately following final session) conducted within 5-10 days apart according to subject availability.
Peak full body center of mass acceleration during gait, expressed as m/sec^2, captured during 30 seconds of treadmill walking at a steady-state, self-selected walking speed.
Pre (same as initial session) and post (immediately following final session) conducted within 5-10 days apart according to subject availability.

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Center of Mass Acceleration Impulse
Tidsramme: Pre (directly prior to initial session) and post (immediately following final session) conducted within 5-10 days apart according to subject availability.
Positive integral of the full body center of mass acceleration during the gait cycle, expressed as an average over all strides captured during 30 seconds of data collection at a steady-state, self-selected walking speed (m/sec).
Pre (directly prior to initial session) and post (immediately following final session) conducted within 5-10 days apart according to subject availability.

Andre resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Self-selected walking speed
Tidsramme: Pre (directly prior to initial session) and post (immediately following final session) conducted within 5-10 days apart according to subject availability.
Walking speed overground for 10 meters, average of 3 timed trials, expressed as m/sec.
Pre (directly prior to initial session) and post (immediately following final session) conducted within 5-10 days apart according to subject availability.
Paretic step ratio
Tidsramme: Pre (directly prior to initial session) and post (immediately following final session) conducted within 5-10 days apart according to subject availability.
Percentage of the total stride completed by paretic step. This is a unit-less measure. Each stride is initiated by foot strike of the paretic leg, and the data are expressed as an average over all strides captured during 30 seconds of data collection at a steady-state, self-selected walking speed.
Pre (directly prior to initial session) and post (immediately following final session) conducted within 5-10 days apart according to subject availability.

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Mark G Bowden, PhD, PTf, Ralph H. Johnson VA Medical Center

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Generelle publikasjoner

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart

1. april 2013

Primær fullføring (Faktiske)

31. mars 2018

Studiet fullført (Faktiske)

31. mars 2018

Datoer for studieregistrering

Først innsendt

3. mai 2016

Først innsendt som oppfylte QC-kriteriene

7. september 2016

Først lagt ut (Anslag)

8. september 2016

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

28. juni 2018

Siste oppdatering sendt inn som oppfylte QC-kriteriene

26. juni 2018

Sist bekreftet

1. juni 2018

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

JA

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere